Skip to main content

Table 1 Patient characteristics and initial clinical status (n = 96, %)

From: Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study

Age, median (range), y

73 (19–88)

Men

72 (75.0)

Cancer type

 lung cancer

40 (41.7)

 Melanoma

17 (17.7)

 Renal cell carcinoma

15 (15.6)

 Stomach cancer

6 (6.3)

 Esophageal cancer

6 (6.3)

 Urothelial cancer

3 (3.1)

 Head and neck cancer

2 (2.1)

 Uterine cancer

2 (2.1)

 Liver cancer

1 (1.0)

 Breast cancer

1 (1.0)

 Colorectal cancer

1 (1.0)

 Hodgkin's lymphoma

1 (1.0)

 Cancer of unknown primary

1 (1.0)

Treatment regimen

 ICI Monotherapy

75 (78.1)

 ICI Combination Chemotherapy

21 (21.9)

Initial response status

 Scheduled outpatient visits

50 (52.1)

 Emergency presentations

46 (47.9)

  1. The placement of Table 1 is on page 12, after Patient demographics
  2. Abbreviations: ICI Immune checkpoint inhibitor, irAEs immune-related adverse event